Quarterly report [Sections 13 or 15(d)]

Consolidated Statement of Stockholders' Equity

v3.26.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   84,613      
Balance at beginning of period at Dec. 31, 2024 $ 516,283 $ 8 $ 886,823 $ (6,823) $ (363,725)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,761      
Common stock issued pursuant to equity awards, net 2,877 $ 1 2,876    
Stock-based compensation 22,871   22,871    
Other comprehensive income (loss) 857     857  
Net loss (49,713)       (49,713)
Balance at end of period (in shares) at Mar. 31, 2025   86,374      
Balance at end of period at Mar. 31, 2025 $ 493,175 $ 9 912,570 (5,966) (413,438)
Balance at beginning of period (in shares) at Dec. 31, 2025 86,451 86,451      
Balance at beginning of period at Dec. 31, 2025 $ 451,895 $ 9 951,262 1,030 (500,406)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   3,078      
Common stock issued pursuant to equity awards, net 28,360   28,360    
Stock-based compensation 19,982   19,982    
Other comprehensive income (loss) (909)     (909)  
Net loss $ (45,137)       (45,137)
Balance at end of period (in shares) at Mar. 31, 2026 89,529 89,529      
Balance at end of period at Mar. 31, 2026 $ 454,191 $ 9 $ 999,604 $ 121 $ (545,543)